Literature DB >> 15932931

Aldosterone induces angiotensin converting enzyme gene expression via a JAK2-dependent pathway in rat endothelial cells.

Toru Sugiyama1, Takanobu Yoshimoto, Kyoichiro Tsuchiya, Naoki Gochou, Yuki Hirono, Toru Tateno, Nozomi Fukai, Masayoshi Shichiri, Yukio Hirata.   

Abstract

Aldosterone is currently recognized as a risk hormone for cardiovascular disease. However, the cellular mechanism by which aldosterone acts on vasculature has not been well understood. In the present study, we investigated whether aldosterone affects angiotensin-converting enzyme (ACE) gene expression in rat endothelial cells. Cultured rat aortic endothelial cells (RAECs) from Sprague-Dawley rats were used in the study. ACE mRNA levels and its enzyme activities in RAECs were examined by real-time RT-PCR and enzyme assay using hippuryl-His-Leu as substrates, respectively. Aldosterone significantly increased steady-state ACE mRNA levels and its enzymatic activities. This effect was dose dependent and time dependent and abolished by mineralocorticoid receptor antagonist spironolactone or transcription inhibitor actinomycin D. Dexamethasone also increased steady-state ACE mRNA levels, whose effect was completely blocked by glucocorticoid receptor antagonist RU486, but not by spironolactone. By contrast, the aldosterone-induced ACE mRNA expression was only partially blocked by RU486. The stimulatory effect of aldosterone on ACE mRNA expression was completely blocked by a protein tyrosine kinase inhibitor (genistein) and JAK2 inhibitor (AG490), partially by Src kinase inhibitor (PP2) and epidermal growth factor receptor kinase inhibitor (AG1478), but not by platelet-derived growth factor receptor kinase inhibitor (AG1296). Transfection of dominant-negative JAK2 construct, but not wild-type construct, significantly blocked the aldosterone-induced ACE mRNA up-regulation. Furthermore, aldosterone induced phosphorylation of JAK2, whose effect was blocked by spironolactone and actinomycin D. In conclusion, the present study demonstrates for the first time that aldosterone induces ACE gene expression and its enzyme activity mainly via a mineralocorticoid receptor-mediated and JAK2-dependent pathway in rat endothelial cells. This may constitute a positive feedback loop for a local renin-angiotensin system, possibly involved in the development of aldosterone-induced endothelial dysfunction and vascular injury.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15932931     DOI: 10.1210/en.2004-1674

Source DB:  PubMed          Journal:  Endocrinology        ISSN: 0013-7227            Impact factor:   4.736


  15 in total

1.  Does aldosterone upregulate the brain renin-angiotensin system in rats with heart failure?

Authors:  Yang Yu; Shun-Guang Wei; Zhi-Hua Zhang; Elise Gomez-Sanchez; Robert M Weiss; Robert B Felder
Journal:  Hypertension       Date:  2008-01-28       Impact factor: 10.190

2.  Aldosterone downregulates delayed rectifier potassium currents through an angiotensin type 1 receptor-dependent mechanism.

Authors:  Yankun Lv; Yanjun Wang; Xiaoran Zhu; Hua Zhang
Journal:  Am J Transl Res       Date:  2018-05-15       Impact factor: 4.060

3.  Central interactions of aldosterone and angiotensin II in aldosterone- and angiotensin II-induced hypertension.

Authors:  Baojian Xue; Terry G Beltz; Yang Yu; Fang Guo; Celso E Gomez-Sanchez; Meredith Hay; Alan Kim Johnson
Journal:  Am J Physiol Heart Circ Physiol       Date:  2010-11-26       Impact factor: 4.733

Review 4.  Therapeutic manipulation of glucocorticoid metabolism in cardiovascular disease.

Authors:  Patrick W F Hadoke; Javaid Iqbal; Brian R Walker
Journal:  Br J Pharmacol       Date:  2009-02-23       Impact factor: 8.739

Review 5.  Aldosterone in salt-sensitive hypertension and metabolic syndrome.

Authors:  Toshiro Fujita
Journal:  J Mol Med (Berl)       Date:  2008-04-25       Impact factor: 4.599

6.  Actions of aldosterone in the cardiovascular system: the good, the bad, and the ugly?

Authors:  Michael Gekle; Claudia Grossmann
Journal:  Pflugers Arch       Date:  2008-11-19       Impact factor: 3.657

Review 7.  Is the mineralocorticoid receptor a potential target for stroke prevention?

Authors:  Jessica M Osmond; Christine' S Rigsby; Anne M Dorrance
Journal:  Clin Sci (Lond)       Date:  2008-01       Impact factor: 6.124

8.  Direct renin inhibition improves systemic insulin resistance and skeletal muscle glucose transport in a transgenic rodent model of tissue renin overexpression.

Authors:  Guido Lastra; Javad Habibi; Adam T Whaley-Connell; Camila Manrique; Melvin R Hayden; Jenna Rehmer; Kamlesh Patel; Carlos Ferrario; James R Sowers
Journal:  Endocrinology       Date:  2009-02-26       Impact factor: 4.736

9.  Aldosterone inhibits the fetal program and increases hypertrophy in the heart of hypertensive mice.

Authors:  Feriel Azibani; Yvan Devaux; Guillaume Coutance; Saskia Schlossarek; Evelyne Polidano; Loubina Fazal; Regine Merval; Lucie Carrier; Alain Cohen Solal; Christos Chatziantoniou; Jean-Marie Launay; Jane-Lise Samuel; Claude Delcayre
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

10.  The epidermal growth factor receptor is involved in angiotensin II but not aldosterone/salt-induced cardiac remodelling.

Authors:  Smail Messaoudi; An Di Zhang; Violaine Griol-Charhbili; Brigitte Escoubet; Junichi Sadoshima; Nicolette Farman; Frederic Jaisser
Journal:  PLoS One       Date:  2012-01-23       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.